Literature DB >> 6167625

Mutationally derived H-2 antigenic differences as defined by cytolytic T lymphocyte clones.

L A Sherman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6167625

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  7 in total

1.  Allospecific T cell recognition of HLA-A2 antigens: evidence for group-specific and subgroup-specific epitopes.

Authors:  L E Wallace; M A Houghton; A B Rickinson; M A Epstein; B A Bradley
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

2.  Immunoselection of structural H-2Kb variants: use of cloned cytolytic T cells to select for loss of a CTL-defined allodeterminant.

Authors:  J M Sheil; M J Bevan; L A Sherman
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

Review 3.  Analysis of structure/function relationships among major histocompatibility complex class I antigens.

Authors:  J A Bluestone
Journal:  Immunol Res       Date:  1987       Impact factor: 2.829

4.  Differential recognition of the serologically defined HLA-A2 antigen by allogeneic cytotoxic T cells. I. Population studies.

Authors:  S Horai; J J van der Poel; E Goulmy
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

5.  Somatic cell variants of H-2Kb: a point mutation in the first extracellular domain results in altered immune recognition.

Authors:  M Nakagawa; R A Zeff; S S Geier; J A Bluestone; S G Nathenson
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

6.  Influence of the major histocompatibility complex on the repertoire of allospecific cytolytic T lymphocytes.

Authors:  L A Sherman
Journal:  J Exp Med       Date:  1982-02-01       Impact factor: 14.307

7.  Allospecific cytolytic T lymphocytes recognize conformational determinants on hybrid mouse transplantation antigens.

Authors:  J A Bluestone; M Foo; H Allen; D Segal; R A Flavell
Journal:  J Exp Med       Date:  1985-07-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.